Molnupiravir influences SARS-CoV-2 evolution in immunocompromised patients

Study found that the antiviral molnupiravir affects the evolution of SARS-CoV-2 in immunocompromised patients, suggesting its use modifies viral mutation patterns and may impact viral evolution.

Masimo wins de novo authorization for measure of high blood oxygen levels

Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Masimo has received de novo

October 16, 2023

Doceree Raises $35M to Expand Healthcare Professional Marketing Globally

What You Should Know: Doceree, the leading global network of physician-only platforms for programmatic messaging, announced a USD 35 million Series B round led by Creaegis, the

September 28, 2023

Why the crowded market for ambient AI medical scribes might be ripe for consolidation

Ambient AI medical scribes are about the easiest — and hottest — way into health care for AI-based startups. Just take a look at this

November 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.